Table 4 The ratio of ADSCs, HSC-progenitors, and AT-ECs based on total number of each injected cell subset

3

N/A

5

N/A

N/A

1

IV + DI

4

4:5:1

0.8

8

IV + DI

4

12:10:1

1.2

9

IV + DI

4

4:3:1

1.33

10

IV + DI

4

4:3:1

1.33

15

IV + DI

4

14:13:1

1.08

17

IV + DI

4

5:4:1

1.25

18

IV + DI

4

5:8:1

0.63

22

IV

4

4:2:1

2.00

25

IV

4

60:9:1

6.67

32

IV

4

11:4:1

2.75

33

IV + DI

4

7:6:1

1.17

Mean ratio of ADSCs to HSC-progenitors

1.84

 6

DI

3

4:0.5:1

8.00

 12

IV + DI

3

3:2:1

1.50

 13

IV + DI

3

3:2:1

1.50

 14

IV + DI

3

8:9:1

0.89

 16

DI

3

15:3:1

5.00

 24

IV

3

5:3:1

1.67

 35

IV + DI

3

14:13:1

1.08

 36

IV + DI

3

2:0.5:1

4.00

 41

IV + DI

3

17:6:1

2.83

 42

IV + DI

3

10:5:1

2.00

Mean ratio of ADSCs to HSC-progenitors

2.85

 2

N/A

2

N/A

N/A

 4

IV

2

11:6:1

1.83

 20

IV + DI

2

23:3:1

7.67

 27

IV + DI

2

11:11:1

1.00

 44

IV + DI

2

2:0.1:1

20.00

Mean ratio of ADSCs to HSC-progenitors

7.63

 21

IV

1

3:1:1

3.00

 23

IV

1

5:1:1

5.00

 26

IV + DI

1

56:80:1

0.70

 28

IV

1

15:12:1

1.25

 30

IV + DI

1

4:1:1

4.00

 31

IV + DI

1

4:1:1

4.00

 34

IV + DI

1

2.5:0.5:1

5.00

 40

DI

1

5:1.5:1

3

 43

IV + DI

1

33:5:1

6.7

Mean ratio of ADSCs to HSC-progenitors

3.63

 5

IV

N/A

55:25:1

2.20

 7

IV

N/A

3:2:1

1.50

 11

IV + DI

N/A

6:1:1

6.00

 19

IV + DI

N/A

272:38:1

7.16

 29

IV + DI

N/A

33:18:1

1.83

 37

IV + DI

N/A

3:34:1

1.0

 38

IV

N/A

41:4:1

10.25

 39

IV + DI

N/A

5:0.5:1

10.00

Mean ratio of ADSCs to HSC-progenitors

4.99